Innovating Works

DEBRA

GENEGRAFT: Phase I II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using... DEBRA INTERNATIONAL GLOBALES EPIDERMOLYSIS BULLOSA SELBSTHILFE-NETZWERK VEREIN participó en un FP7: RDEB is one of the most severe rare genetic skin diseases of children and adults characterized by skin blistering resulting from lack of ex...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.